Adagio Medical (ADGM) Competitors $1.65 -0.19 (-10.33%) (As of 12/20/2024 05:15 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends ADGM vs. TELA, GUTS, MGRM, TMDIF, LNSR, WOK, NSPR, APYX, HSAQ, and DHAIShould you be buying Adagio Medical stock or one of its competitors? The main competitors of Adagio Medical include TELA Bio (TELA), Fractyl Health (GUTS), Monogram Orthopaedics (MGRM), Titan Medical (TMDIF), LENSAR (LNSR), WORK Medical Technology Group LTD Ordinary Shares (WOK), InspireMD (NSPR), Apyx Medical (APYX), Health Sciences Acquisitions Co. 2 (HSAQ), and DIH Holding US (DHAI). These companies are all part of the "surgical & medical instruments" industry. Adagio Medical vs. TELA Bio Fractyl Health Monogram Orthopaedics Titan Medical LENSAR WORK Medical Technology Group LTD Ordinary Shares InspireMD Apyx Medical Health Sciences Acquisitions Co. 2 DIH Holding US TELA Bio (NASDAQ:TELA) and Adagio Medical (NASDAQ:ADGM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, earnings, valuation, dividends, profitability and media sentiment. Which has better valuation & earnings, TELA or ADGM? Adagio Medical has lower revenue, but higher earnings than TELA Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$68.65M1.64-$46.66M-$1.69-1.69Adagio Medical$266K90.16-$2.13MN/AN/A Do institutionals and insiders believe in TELA or ADGM? 94.3% of TELA Bio shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 6.0% of TELA Bio shares are held by company insiders. Comparatively, 53.5% of Adagio Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts recommend TELA or ADGM? TELA Bio currently has a consensus target price of $9.25, suggesting a potential upside of 224.56%. Given TELA Bio's stronger consensus rating and higher possible upside, research analysts clearly believe TELA Bio is more favorable than Adagio Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Adagio Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is TELA or ADGM more profitable? Adagio Medical has a net margin of 0.00% compared to TELA Bio's net margin of -60.49%. Adagio Medical's return on equity of 160.59% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-60.49% -556.18% -63.13% Adagio Medical N/A 160.59%40.99% Does the media refer more to TELA or ADGM? In the previous week, Adagio Medical had 3 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Adagio Medical and 0 mentions for TELA Bio. Adagio Medical's average media sentiment score of 0.22 beat TELA Bio's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the news media. Company Overall Sentiment TELA Bio Neutral Adagio Medical Neutral Does the MarketBeat Community prefer TELA or ADGM? TELA Bio received 59 more outperform votes than Adagio Medical when rated by MarketBeat users. CompanyUnderperformOutperformTELA BioOutperform Votes5974.68% Underperform Votes2025.32% Adagio MedicalN/AN/A Which has more volatility & risk, TELA or ADGM? TELA Bio has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Adagio Medical has a beta of -0.09, indicating that its stock price is 109% less volatile than the S&P 500. SummaryAdagio Medical beats TELA Bio on 8 of the 15 factors compared between the two stocks. Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Get Adagio Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ADGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADGM vs. The Competition Export to ExcelMetricAdagio MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.98M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E RatioN/A25.0190.0517.18Price / Sales90.1645.901,116.25117.05Price / CashN/A43.4443.1037.85Price / Book-0.477.094.784.78Net Income-$2.13M$13.64M$120.31M$225.60M7 Day Performance-18.32%-2.93%-1.92%-1.23%1 Month Performance-33.20%-1.42%13.65%0.46%1 Year PerformanceN/A39.20%28.34%15.24% Adagio Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADGMAdagio MedicalN/A$1.65-10.3%N/AN/A$23.98M$266,000.000.0085News CoverageGap DownHigh Trading VolumeTELATELA Bio2.9878 of 5 stars$2.83+2.2%$9.25+226.9%-53.6%$111.47M$58.45M-1.64120GUTSFractyl Health0.8734 of 5 stars$2.12+3.9%$22.00+937.7%N/A$101.97M$120,000.00-0.17102MGRMMonogram Orthopaedics3.2283 of 5 stars$2.76+3.8%$4.00+44.9%-23.1%$94.70M$364,999.00-5.6628Gap DownTMDIFTitan MedicalN/A$0.82-6.8%N/A+563.3%$93.23M$17.63M11.004News CoverageLNSRLENSAR0.5735 of 5 stars$7.53-0.3%$8.00+6.2%+174.0%$87.46M$48.87M-5.17110News CoverageWOKWORK Medical Technology Group LTD Ordinary SharesN/A$5.48+0.4%N/AN/A$79.46MN/A0.00226Gap UpHigh Trading VolumeNSPRInspireMD2.1916 of 5 stars$3.00+1.7%$4.75+58.3%+45.6%$78.25M$6.82M-3.9350Analyst ForecastGap UpAPYXApyx Medical1.6476 of 5 stars$1.77+5.4%N/A-37.5%$66.63M$48.54M-2.23270HSAQHealth Sciences Acquisitions Co. 2N/A$5.26-1.5%N/A-48.0%$58.98MN/A0.004Gap DownDHAIDIH Holding USN/A$1.39-0.7%N/AN/A$56.37M$64.47M0.00N/A Related Companies and Tools Related Companies TELA Bio Alternatives Fractyl Health Alternatives Monogram Orthopaedics Alternatives Titan Medical Alternatives LENSAR Alternatives WORK Medical Technology Group LTD Ordinary Shares Alternatives InspireMD Alternatives Apyx Medical Alternatives Health Sciences Acquisitions Co. 2 Alternatives DIH Holding US Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ADGM) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagio Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagio Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.